Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 8 studies | 20% ± 3% | |
pericyte | 5 studies | 21% ± 4% | |
connective tissue cell | 4 studies | 22% ± 4% | |
myofibroblast cell | 3 studies | 20% ± 4% | |
retina horizontal cell | 3 studies | 27% ± 9% |
Insufficient scRNA-seq data for expression of FZD1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 2766.85 | 245 / 245 | 94% | 24.05 | 470 / 502 |
thymus | 100% | 7690.46 | 653 / 653 | 93% | 96.21 | 565 / 605 |
lung | 100% | 3426.43 | 576 / 578 | 88% | 27.70 | 1021 / 1155 |
breast | 93% | 2339.85 | 425 / 459 | 95% | 37.08 | 1067 / 1118 |
kidney | 94% | 1982.55 | 84 / 89 | 91% | 85.99 | 817 / 901 |
esophagus | 99% | 1648.46 | 1429 / 1445 | 84% | 27.70 | 154 / 183 |
uterus | 99% | 2379.63 | 168 / 170 | 80% | 21.13 | 369 / 459 |
skin | 100% | 3546.12 | 1808 / 1809 | 75% | 25.41 | 356 / 472 |
pancreas | 77% | 781.04 | 251 / 328 | 92% | 23.32 | 163 / 178 |
ovary | 100% | 3214.51 | 180 / 180 | 68% | 15.97 | 292 / 430 |
bladder | 100% | 2266.52 | 21 / 21 | 57% | 11.88 | 288 / 504 |
intestine | 98% | 1805.13 | 942 / 966 | 49% | 8.51 | 260 / 527 |
stomach | 82% | 1048.58 | 296 / 359 | 60% | 11.89 | 171 / 286 |
adrenal gland | 86% | 1268.34 | 223 / 258 | 23% | 4.51 | 52 / 230 |
blood vessel | 100% | 6743.54 | 1334 / 1335 | 0% | 0 | 0 / 0 |
brain | 49% | 557.56 | 1307 / 2642 | 45% | 10.13 | 319 / 705 |
adipose | 94% | 1854.72 | 1136 / 1204 | 0% | 0 | 0 / 0 |
heart | 85% | 1710.45 | 735 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 80% | 18.67 | 36 / 45 |
spleen | 41% | 381.02 | 99 / 241 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 20% | 2.34 | 16 / 80 |
liver | 3% | 28.43 | 7 / 226 | 15% | 4.21 | 60 / 406 |
muscle | 10% | 92.54 | 78 / 803 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 7% | 0.76 | 2 / 29 |
peripheral blood | 3% | 21.99 | 27 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0003151 | Biological process | outflow tract morphogenesis |
GO_1905606 | Biological process | regulation of presynapse assembly |
GO_0035425 | Biological process | autocrine signaling |
GO_1903377 | Biological process | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway |
GO_0051091 | Biological process | positive regulation of DNA-binding transcription factor activity |
GO_1904948 | Biological process | midbrain dopaminergic neuron differentiation |
GO_0045446 | Biological process | endothelial cell differentiation |
GO_0010976 | Biological process | positive regulation of neuron projection development |
GO_0003149 | Biological process | membranous septum morphogenesis |
GO_0001934 | Biological process | positive regulation of protein phosphorylation |
GO_0030514 | Biological process | negative regulation of BMP signaling pathway |
GO_2000739 | Biological process | regulation of mesenchymal stem cell differentiation |
GO_0090090 | Biological process | negative regulation of canonical Wnt signaling pathway |
GO_0045669 | Biological process | positive regulation of osteoblast differentiation |
GO_0007267 | Biological process | cell-cell signaling |
GO_0060070 | Biological process | canonical Wnt signaling pathway |
GO_0044338 | Biological process | canonical Wnt signaling pathway involved in mesenchymal stem cell differentiation |
GO_0090179 | Biological process | planar cell polarity pathway involved in neural tube closure |
GO_0030182 | Biological process | neuron differentiation |
GO_0003150 | Biological process | muscular septum morphogenesis |
GO_0007186 | Biological process | G protein-coupled receptor signaling pathway |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0099054 | Biological process | presynapse assembly |
GO_0060022 | Biological process | hard palate development |
GO_0036520 | Biological process | astrocyte-dopaminergic neuron signaling |
GO_0035567 | Biological process | non-canonical Wnt signaling pathway |
GO_0009410 | Biological process | response to xenobiotic stimulus |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_0005886 | Cellular component | plasma membrane |
GO_0005925 | Cellular component | focal adhesion |
GO_0009986 | Cellular component | cell surface |
GO_1990909 | Cellular component | Wnt signalosome |
GO_0017147 | Molecular function | Wnt-protein binding |
GO_0004930 | Molecular function | G protein-coupled receptor activity |
GO_0005109 | Molecular function | frizzled binding |
GO_0005102 | Molecular function | signaling receptor binding |
GO_0042813 | Molecular function | Wnt receptor activity |
GO_0030165 | Molecular function | PDZ domain binding |
GO_0005515 | Molecular function | protein binding |
Gene name | FZD1 |
Protein name | Frizzled-1 (Fz-1) (hFz1) (FzE1) |
Synonyms | |
Description | FUNCTION: Receptor for Wnt proteins . Activated by WNT3A, WNT3, WNT1 and to a lesser extent WNT2, but apparently not by WNT4, WNT5A, WNT5B, WNT6, WNT7A or WNT7B . Contradictory results showing activation by WNT7B have been described for mouse (By similarity). Functions in the canonical Wnt/beta-catenin signaling pathway . The canonical Wnt/beta-catenin signaling pathway leads to the activation of disheveled proteins, inhibition of GSK-3 kinase, nuclear accumulation of beta-catenin and activation of Wnt target genes . A second signaling pathway involving PKC and calcium fluxes has been seen for some family members, but it is not yet clear if it represents a distinct pathway or if it can be integrated in the canonical pathway, as PKC seems to be required for Wnt-mediated inactivation of GSK-3 kinase. Both pathways seem to involve interactions with G-proteins. May be involved in transduction and intercellular transmission of polarity information during tissue morphogenesis and/or in differentiated tissues (Probable). .; FUNCTION: (Microbial infection) Acts as a receptor for C.difficile toxin TcdB in the colonic epithelium. . |
Accessions | ENST00000287934.4 Q9UP38 |